AKYA: Akoya BioSciences Inc. Stocks News on June 2, 2025

AKYA

PR Newswire

10 days ago

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal

AKYA

MT Newswires

12 days ago

Sector Update: Health Care Stocks Slide Wednesday Afternoon

AKYA

MT Newswires

12 days ago

Akoya Biosciences Receives Unsolicited Buyout Offer From Third Party

AKYA

Zacks

21 days ago

Akoya Biosciences (AKYA) Reports Q1 Loss, Misses Revenue Estimates

AKYA

Associated Press Finance

21 days ago

Akoya: Q1 Earnings Snapshot

Akoya Biosciences Reports First Quarter 2025 Financial Results

AKYA

GlobeNewswire

21 days ago

Akoya Biosciences Reports First Quarter 2025 Financial Results

AKYA

Zacks

a month ago

Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zealand Pharma AS (ZLDPF) Stock Jumps 8.0%: Will It Continue to Soar?

AKYA

Zacks

a month ago

Zealand Pharma AS (ZLDPF) Stock Jumps 8.0%: Will It Continue to Soar?

AKYA

MT Newswires

a month ago

Quanterix, Akoya Biosciences Amend Merger Deal

AKYA

Business Wire

a month ago

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025

AKYA

GlobeNewswire

a month ago

Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025

Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas

AKYA

GlobeNewswire

a month ago

Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas

Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore

AKYA

GlobeNewswire

a month ago

Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore

Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities

AKYA

GlobeNewswire

2 months ago

Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities

AKYA

MT Newswires

2 months ago

Akoya Biosciences Shares Fall After Downgrade From Stephens

AKYA

MT Newswires

2 months ago

Stephens Downgrades Akoya Biosciences to Equalweight From Overweight, Price Target is $1.80

AKYA

Thomson Reuters StreetEvents

2 months ago

Q4 2024 Quanterix Corp Earnings Call

Quanterix Corp (QTRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges

AKYA

GuruFocus.com

2 months ago

Quanterix Corp (QTRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges

AKYA

Zacks

3 months ago

Akoya Biosciences (AKYA) Reports Q4 Loss, Lags Revenue Estimates

AKYA

Associated Press Finance

3 months ago

Akoya: Q4 Earnings Snapshot

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results

AKYA

GlobeNewswire

3 months ago

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results

AKYA

MT Newswires

3 months ago

Quanterix Shareholder Opposes Proposed Akoya Biosciences Merger

AKYA

MT Newswires

3 months ago

Piper Sandler Downgrades Akoya Biosciences to Neutral From Overweight, Adjusts Price Target to $2.40 From $3

Akoya Biosciences unveils strategic product roadmap

AKYA

TipRanks

4 months ago

Akoya Biosciences unveils strategic product roadmap

AKYA

GlobeNewswire

4 months ago

Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels

AKYA

MT Newswires

5 months ago

Canaccord Genuity Downgrades Akoya Biosciences to Hold From Buy, $3.50 Price Target

AKYA

MT Newswires

5 months ago

Top Premarket Gainers

AKYA

MT Newswires

5 months ago

Quanterix Agrees to Acquire Akoya Biosciences in All-Stock Deal

AKYA

Business Wire

5 months ago

Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers

AKYA

MT Newswires

6 months ago

Akoya Biosciences Secures Exclusive License for NeraCare's Immunoprint Test

Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions

AKYA

GlobeNewswire

6 months ago

Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions

Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone

AKYA

GlobeNewswire

6 months ago

Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone

AKYA

Simply Wall St.

7 months ago

Time To Worry? Analysts Just Downgraded Their Akoya Biosciences, Inc. (NASDAQ:AKYA) Outlook

Akoya Biosciences Third Quarter 2024 Earnings: Misses Expectations

AKYA

Simply Wall St.

7 months ago

Akoya Biosciences Third Quarter 2024 Earnings: Misses Expectations

AKYA

GuruFocus.com

7 months ago

Akoya Biosciences Inc (AKYA) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ...

AKYA

Zacks

7 months ago

Akoya Biosciences (AKYA) Reports Q3 Loss, Lags Revenue Estimates

AKYA

Associated Press Finance

7 months ago

Akoya: Q3 Earnings Snapshot

Akoya Biosciences Reports Third Quarter 2024 Financial Results

AKYA

GlobeNewswire

7 months ago

Akoya Biosciences Reports Third Quarter 2024 Financial Results

AKYA

GuruFocus.com

7 months ago

Akoya Biosciences Inc (AKYA) Q3 2024 Earnings Report Preview: What To Look For

Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode™ Discovery IO60 and Mouse FFPE IO Panel

AKYA

GlobeNewswire

7 months ago

Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode™ Discovery IO60 and Mouse FFPE IO Panel

Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024

AKYA

GlobeNewswire

7 months ago

Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024

AKYA

MT Newswires

8 months ago

Akoya Biosciences Spatial Proteomics Platform to be Used in Cancer Immunotherapy Consortium

Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy

AKYA

GlobeNewswire

8 months ago

Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy

AKYA

MT Newswires

8 months ago

Akoya Biosciences Appoints Scott Mendel as Chairman

Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors

AKYA

GlobeNewswire

8 months ago

Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors

Akoya Biosciences Second Quarter 2024 Earnings: Revenues Disappoint

AKYA

Simply Wall St.

10 months ago

Akoya Biosciences Second Quarter 2024 Earnings: Revenues Disappoint

AKYA

MT Newswires

10 months ago

Morgan Stanley Downgrades Akoya Biosciences to Equalweight From Overweight, Adjusts PT to $3 From $4

AKYA

MT Newswires

10 months ago

BTIG Research Downgrades Akoya Biosciences to Neutral From Buy

AKYA

MT Newswires

10 months ago

JPMorgan Downgrades Akoya Biosciences to Neutral From Overweight

AKYA

Zacks

10 months ago

Akoya Biosciences (AKYA) Reports Q2 Loss, Misses Revenue Estimates

AKYA

Associated Press Finance

10 months ago

Akoya: Q2 Earnings Snapshot

Akoya Biosciences Reports Second Quarter 2024 Financial Results

AKYA

GlobeNewswire

10 months ago

Akoya Biosciences Reports Second Quarter 2024 Financial Results

Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences

AKYA

GlobeNewswire

a year ago

Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences

AKYA

Simply Wall St.

a year ago

While institutions own 21% of Akoya Biosciences, Inc. (NASDAQ:AKYA), private equity firms are its largest shareholders with 49% ownership

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

AKYA

GuruFocus.com

a year ago

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

AKYA

Energy Global

a year ago

ANDRITZ to equip new Silvan hydropower plant in Türkiye

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

AKYA

USA TODAY

a year ago

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

AKYA

Business Wire

a year ago

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

AKYA

Business Wire

a year ago

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

SEALSQ to Launch Two New Quantum Resistant Chips

AKYA

GlobeNewswire

a year ago

SEALSQ to Launch Two New Quantum Resistant Chips

AKYA

Reuters

a year ago

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

AKYA

GlobeNewswire

a year ago

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

AKYA

MT Newswires

a year ago

Morgan Stanley Cuts Akoya Biosciences Price Target to $4 From $8, Maintains Overweight Rating

AKYA

Simply Wall St.

a year ago

We Think Some Shareholders May Hesitate To Increase Akoya Biosciences, Inc.'s (NASDAQ:AKYA) CEO Compensation

AKYA

MT Newswires

a year ago

Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating

AKYA

MT Newswires

a year ago

Top Midday Decliners

AKYA

GuruFocus.com

a year ago

Akoya Biosciences Inc (AKYA) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...

AKYA

MT Newswires

a year ago

Top Premarket Decliners

AKYA

Zacks

a year ago

Akoya Biosciences (AKYA) Reports Q1 Loss, Lags Revenue Estimates

AKYA

Associated Press Finance

a year ago

Akoya: Q1 Earnings Snapshot

Akoya Biosciences Reports First Quarter 2024 Financial Results

AKYA

GlobeNewswire

a year ago

Akoya Biosciences Reports First Quarter 2024 Financial Results

Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients

AKYA

GlobeNewswire

a year ago

Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients

AKYA

Zacks

a year ago

Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts

AKYA

GlobeNewswire

a year ago

Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows

AKYA

GlobeNewswire

a year ago

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024

AKYA

GlobeNewswire

a year ago

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024

Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale

AKYA

GlobeNewswire

a year ago

Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale

AKYA

Insider Monkey

a year ago

Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2023 Earnings Call Transcript

AKYA

Thomson Reuters StreetEvents

a year ago

Q4 2023 Akoya Biosciences Inc Earnings Call

AKYA

GuruFocus.com

a year ago

Akoya Biosciences Inc (AKYA) Reports Record Q4 Revenue and Sets Positive 2024 Outlook

AKYA

Zacks

a year ago

Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates

AKYA

Associated Press Finance

a year ago

Akoya: Q4 Earnings Snapshot

Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook

AKYA

GlobeNewswire

a year ago

Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook

Has Acumen Pharmaceuticals (ABOS) Outpaced Other Medical Stocks This Year?

AKYA

Zacks

a year ago

Has Acumen Pharmaceuticals (ABOS) Outpaced Other Medical Stocks This Year?

Akoya Biosciences Insiders Placed Bullish Bets Worth US$2.11m

AKYA

Simply Wall St.

a year ago

Akoya Biosciences Insiders Placed Bullish Bets Worth US$2.11m

Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?

AKYA

Zacks

a year ago

Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?

Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference

AKYA

GlobeNewswire

a year ago

Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference

AKYA

Zacks

a year ago

Strength Seen in Akoya (AKYA): Can Its 7.4% Jump Turn into More Strength?

Chuck Royce Reduces Stake in Lincoln Educational Services Corp

AKYA

GuruFocus.com

a year ago

Chuck Royce Reduces Stake in Lincoln Educational Services Corp

Bristol Myers' (BMY) sBLAs for Breyanzi Get FDA Priority Tag

AKYA

Zacks

a year ago

Bristol Myers' (BMY) sBLAs for Breyanzi Get FDA Priority Tag

NexPoint Real Estate Finance Announces 2023 Dividend Income Tax Treatment

AKYA

PR Newswire

a year ago

NexPoint Real Estate Finance Announces 2023 Dividend Income Tax Treatment

Alerus Financial Corporation (NASDAQ:ALRS) Q4 2023 Earnings Call Transcript

AKYA

Insider Monkey

a year ago

Alerus Financial Corporation (NASDAQ:ALRS) Q4 2023 Earnings Call Transcript

Is Abbott Laboratories (ABT) Stock Outpacing Its Medical Peers This Year?

AKYA

Zacks

a year ago

Is Abbott Laboratories (ABT) Stock Outpacing Its Medical Peers This Year?

Should Value Investors Buy Brinker International (EAT) Stock?

AKYA

Zacks

a year ago

Should Value Investors Buy Brinker International (EAT) Stock?

Univest Financial Corp (UVSP) Reports Mixed Results for Q4 and Full Year 2023

AKYA

GuruFocus.com

a year ago

Univest Financial Corp (UVSP) Reports Mixed Results for Q4 and Full Year 2023

AKYA

Associated Press Finance

a year ago

Hanmi Financial: Q4 Earnings Snapshot

AKYA

GlobeNewswire

a year ago

Diamond Equity Research to Host Spotlight Emerging Growth Invitational Virtual Investor Conference on January 23, 2024

Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases

AKYA

GlobeNewswire

a year ago

Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases

Sweetgreen (SG) Expands Domestic Footprint With New Location

AKYA

Zacks

a year ago

Sweetgreen (SG) Expands Domestic Footprint With New Location

Investors in Diamond Hill Investment Group (NASDAQ:DHIL) have unfortunately lost 11% over the last year

AKYA

Simply Wall St.

a year ago

Latest Akoya BioSciences Inc. (AKYA) News on June 2, 2025

Share on Social Networks: